Amundi’s Trueblue TBI Stock Holding History

Amundi’s Portfolio TBI Stock Details TBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,660	Closed	-$65.3K	–	2074
2023 Q4	$65.3K	Buy	4,660 +309	+7%	+$4.32K	﹤0.01%	1852
2023 Q3	$63.5K	Hold	4,351	–	–	﹤0.01%	1834
2023 Q2	$77.3K	Sell	4,351 -611	-12%	-$10.4K	﹤0.01%	1826
2023 Q1	$86.6K	Buy	+4,962	New	+$92.8K	﹤0.01%	1785

Other funds holding TBI

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

ACM

Azarias Capital Management Berwyn, Pennsylvania $230M AUM 39.35% 1-Year Est. Return

Amundi's TBI Position: Q1 2024 in Review

Amundi sold out of Trueblue (TBI) in Q1 2024, closing a stake of 4,660 shares — an estimated $65.3K sold.

Amundi first reported a position in TBI in Q1 2023 and held it in 4 quarters. The position peaked at $86.6K in Q1 2023. 137 funds tracked by Wall St. Rank hold TBI as of Q1 2024.

Amundi reported no remaining Trueblue position as of Q1 2024 after selling out during the quarter.
Amundi sold 4,660 Trueblue shares in Q1 2024, an estimated $65.3K.
Amundi first reported a position in Trueblue in Q1 2023 and held it in 4 quarters.
Amundi's Trueblue position peaked at $86.6K in Q1 2023.
137 funds tracked by Wall St. Rank held Trueblue as of Q1 2024.

Based on Amundi's 13F filing for Q1 2024, filed 15 May 2024.